QHSLab (USAQ) Stock Price, News & Analysis

Company Overview

QHSLab, Inc. is a healthcare technology and diagnostics company focused on supporting personalized medicine and clinical decision-making. The company develops and provides laboratory testing services and related software designed to help healthcare providers evaluate patient data and guide individualized treatment plans.

QHSLab’s offerings are intended to combine diagnostic testing with digital tools, data analysis and clinical insights. Its services support areas such as disease assessment, treatment monitoring and patient management, although publicly available information about the company’s complete product portfolio and geographic reach is limited.

The company’s solutions are primarily directed toward healthcare professionals and organizations seeking more data-driven approaches to patient care. Detailed information about QHSLab’s leadership, corporate history and operating locations is not readily available from reliable public sources.

Key Stats

• Today's Range: $0.32 to $0.39
• 50-Day Range: $0.23 to $0.40
• 52-Week Range: $0.08 to $1.14
• Volume: 1,600 shs
• Average Volume: 3,135 shs
• Market Capitalization: $3.61 million
• P/E Ratio: 10.67
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

QHSLab Stock Analysis - MarketRank™

QHSLab scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for QHSLab.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of QHSLab is 10.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.81.

Price to Earnings Ratio vs. Sector

The P/E ratio of QHSLab is 10.67, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.77.

Price to Book Value per Share Ratio

QHSLab has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of QHSLab has been sold short.

Short Interest Ratio / Days to Cover

QHSLab has a short interest ratio ("days to cover") of 0.04, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in QHSLab has recently increased by 100.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

QHSLab does not currently pay a dividend.

Dividend Growth

QHSLab does not have a long track record of dividend growth.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: -0.01

News Sentiment

QHSLab has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for QHSLab this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, QHSLab insiders have not sold or bought any company stock.

Percentage Held by Insiders

74.19% of the stock of QHSLab is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

QHSLab has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/14/2025
• Today: 9/29/2026
• Next Earnings (Estimated): 11/17/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:USAQ
• CIK: 856984
• Web: www.qhslab.com
• Phone: (929) 379-6503
• Fax: N/A
• Employees: 12
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.03
• Trailing P/E Ratio: 10.67
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $460 thousand
• Net Margins: 17.36%
• Pretax Margin: 17.35%
• Return on Equity: -3.91%
• Return on Assets: -2.07%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.82
• Quick Ratio: 1.79

Sales & Book Value

• Annual Sales: $2.69 million
• Price / Sales: 1.34
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.14 per share
• Price / Book: 2.29

Miscellaneous

• Outstanding Shares: 11,280,000
• Free Float: 2,912,000
• Market Cap: $3.61 million
• Optionable: Not Optionable
• Beta: 0.66